Impact of the HELPeN Program on Social Isolation in Community-dwelling Elders (HELPeN) (HELPeN)

December 8, 2022 updated by: MARIA RUZAFA MARTINEZ

Impact of the HELPeN Telecare Program on Social Isolation and Loneliness in Community-dwelling Elders: Randomized Control Trial

The main objective is to determine the effectiveness of the HELPeN Program, a 12-month telephone telenursing program for community-dwelling elderly in social isolation, evaluating the main changes in levels of social isolation, loneliness, quality of life, mental health status (depression), sleep and functional capacity, as well as changes in care management (demand for services and consumption of drugs).

Methodology Two-arm parallel stratified randomized clinical trial with 12 months duration performing measurements at time 0, 3, 6, 6, 9 and 12 months.

Participating subjects will be selected by nursing professionals from users of Area 3 of Health of the Region of Murcia over 65 years old, residing in the community and with a Social Isolation score <32 (Low perceived social support with DUFSS). Randomization will be performed after stratification according to whether the subjects live alone or accompanied, with a 1:1 ratio. Given an alpha level of 0.05, an anticipated effect size of 1.58, beta power equal to 1, 42 subjects are required in each group.

The intervention consists of a telephonic telenursing program HELPeN (Help eNursing) to be carried out in collaboration with the Poncemar Volunteer Bank.

The control group will not receive any intervention.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Murcia
      • Lorca, Murcia, Spain, 30817
        • Recruiting
        • Healthcare Area III. Region of Murcia
        • Contact:
        • Contact:
        • Principal Investigator:
          • César Leal-Costa, RN, PhD
        • Sub-Investigator:
          • María Ruzafa-Martínez, RN, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • score < 32 (Low perceived social support with the DUFSS scale)
  • Residence in the community

Exclusion Criteria:

  • Severe cognitive impairment (8-10 errors on the Pfeiffer test)
  • Non Spanish speakers
  • Failure to consent to the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group

The proposed intervention is a telephonic telenursing program aimed at managing social isolation in the elderly, the HELPeN (Help eNursing) program.

The operational part of the intervention will be carried out by volunteers nursing students from the University of Murcia enrolled in the academic years 2020-2023. To ensure homogeneity in the intervention carried out by the volunteers they will receive a 15-hour training oriented to ensure the acquisition of essential communication skills for the implementation of the intervention and to know the specific interventions of support and counseling for the elderly in social isolation.

The proposed intervention is a telephonic telenursing program aimed at managing social isolation in the elderly, the HELPeN (Help eNursing) program.

The operational part of the intervention will be carried out by volunteers nursing students from the University of Murcia enrolled in the academic years 2020-2023. To ensure homogeneity in the intervention carried out by the volunteers they will receive a 15-hour training oriented to ensure the acquisition of essential communication skills for the implementation of the intervention and to know the specific interventions of support and counseling for the elderly in social isolation.

Over the 36 weeks of the HELPeN Program, each volunteer is expected to provide intervention to 2 seniors, making 1 call per week to each subject lasting approximately 30 minutes. Students will perform physical and psychosocial assessments of the elders and create individualized care plans based on each subject's needs.

No Intervention: Control group
No intervention will be performed in the control group and the subjects will be contacted on the same dates as the intervention group for data collection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Loneliness
Time Frame: 9 months

Name of the measurement: Loneliness

Definition: Loneliness is the result of a cognitive evaluation where there are discrepancies between the social relationships that people desire and those that they really have.

Measuremente tool: UCLA Loniness Scale. Developed by psychologist Daniel Russell (1996), the UCLA Loneliness Scale (Version 3) is a 20-item measure that assesses how often a person feels disconnected from others.

Unit of measure: Indicence of loneliness

9 months
Social isolation
Time Frame: 9 months

Name of the measurement: Social isolation

Definition: Disengagement from social relationships, connections with institutions or community involvement.

Measurement tool: DUKE-UNC Functional Social Support questionnaire(DUFSS). A 14-item, self-administered, multidimensional, functional social support questionnaire.

Unit of measure: Incidence of social isolation

9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phisycal function
Time Frame: 9 months

Name of the measurement: Phisycal function

Definition: The level of functional independence of patients with neuromuscular and musculoskeletal pathologies

Measurement tool: Barthel Index for Activities of Daily Living. Scale used to measure performance in activities of daily living (ADL). Ten variables describing ADL and mobility are scored, a higher number being a reflection of greater ability to function independently following hospital discharge.

Unit of measure: % of subjects "able to live independently"; "minimally dependent"; "partially dependent"; "very dependent"; "total dependece"

9 months
Depression
Time Frame: 9 months

Name of the measurment: Depression

Definition: Depression is a common but serious mood disorder. It causes severe symptoms that affect how you feel, think, and handle daily activities, such as sleeping, eating, or working.

Measurement tool: Geriatric Depression Scale (GDS). The original scale consists of 30 dichotomous items (Yes/No), and direct scoring, between 0 and 30.

Unit of measure: Incidence of depression and mean punctuation in the GDS scale

9 months
Mental status
Time Frame: 9 months

Name of the measurement: Mental status

Definition:

Measuremente tool: Short portable mental status questionnaire (SPMSQ) (Pfeiffer's test). It is a brief questionnaire composed of ten questions that measure the degree of cognitive impairment. Evaluates cognitive impairment for the purpose of screening for dementia. Heteroapplied.

Unit of measure: Incidence of cognitive impairment and % of subject with "intact intellectual functioning"; "intact intellectual functioning"; "moderate intellectual impairment" and "severe intellectual impairment"

9 months
Anxiety
Time Frame: 9 months

Name of the measuremente: Anxiety

Definition: Generalized anxiety disorder (GAD) include clearly excessive, uncontrollable, and often irrational anxiety and worry of a duration of at least 6 months

Measuremente tool: 7-item Generalized Anxiety Disorder Scale (GAD-7). It is a 7 items self-report scale designed to identify probable cases of GAD.

Unit of measure: % of subjects with "minimal anxiety"; "mild anxiety"; "severe anxiety"

9 months
Health Related Quality of life
Time Frame: 9 months

Name of the measurement: Health Related Quality of life

Definition: It encompass those aspects of overall quality of life that can be clearly shown to affect health-either physical or mental

Measuremente tool: European Quality of Life-5 Dimension (EQ-5D). It can be used at the individual level to monitor a patient's health status over time. The EQ-5D instrument consists of 2 parts - the EQ-5D descriptive system and the Visual Analog Scale (VAS). The EQ-5D descriptive system comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. In the VAS the individual scores his or her health between two extremes, 0 and 100, the worst and the best state of health imaginable.

Unit of measure: % of subjects reporting health problems by level in each dimension. Mean punctuation of the VAS scale.

9 months
Health assistance
Time Frame: 9 months

Name of the measurement: Health assistance

Definition: Health care provided to a patient including: hospitalization, face-to-face or telephone consultation, home care, visit to emergency department and the professional providing the care.

Measuremente tool: these information will be collected from electronic record of the patients

Unit of measure:% of subjects requiring health assistance: hospitalization, face-to-face or telephone consultation, home care, visit to emergency department and the professional providing the care.

9 months
Drugs
Time Frame: 9 months

Name of the measurement: Consumption of drugs

Definition: the prescription or increase in daily dosage, according to the anatomical-therapeutic classification (ATC) of the WHO, of the following drugs will be recorded: Psycholeptics, Psychoanaleptics, Analgesics, Muscle relaxants and Other drugs.

Measuremente tool: prescriptions will be collected from electronic record of the patients

Unit of measure: % of subjects taking Psycholeptics, Psychoanaleptics, Analgesics, Muscle relaxants and Other drugs.

9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: César Leal-Costa, RN, PhD, Universidad de Murcia
  • Principal Investigator: María Ruzafa-Martínez, RN, PhD, Universidad de Murcia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2022

Primary Completion (Anticipated)

May 31, 2024

Study Completion (Anticipated)

December 31, 2025

Study Registration Dates

First Submitted

November 26, 2022

First Submitted That Met QC Criteria

December 8, 2022

First Posted (Estimate)

December 9, 2022

Study Record Updates

Last Update Posted (Estimate)

December 9, 2022

Last Update Submitted That Met QC Criteria

December 8, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PI21/00984

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Loneliness

Clinical Trials on Help eNursing

Subscribe